Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and ...

Moleculin Biotech (MBRX) announced updates to its active site status and recruitment for its pivotal Phase 2B/3, multi-center, randomized, double-blind, placebo-controlled, adaptive design study of ...

Daily squirts of a safe, over-the-counter allergy nasal spray may prevent COVID-19 infections from taking hold, according to ...

Q32 Bio Inc (($QTTB)) announced an update on their ongoing clinical study. Study Overview: Q32 Bio Inc. is conducting a Phase 2a proof-of-concept ...

European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited ...

Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with ...

This phase II/III double-blind study assessed efficacy and safety of cediranib with standard chemotherapy as initial therapy for advanced non–small-cell lung cancer (NSCLC). Although all authors ...

As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at two years ...

Hand-foot syndrome (HFS) is a dose-limiting side effect of capecitabine. Celecoxib prevents HFS by inhibiting cyclooxygenase-2 (COX-2) that is upregulated because of the underlying associated ...